MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)
Phase II/III Study to Investigate the Effects of Fingolimod Versus Interferon Beta-1b on Visual Recovery After Optic Neuritis Phase II/III Study to Investigate the Effects of Fingolimod Versus Interferon Beta-1b on Visual Reco ...
Multiple Sclerosis
Drug: Verum arm receiving Gilenya®;Drug: Active Comparator receiving Extavia®
Charite University, Berlin, Germany
NeuroCure Clinical Research Center, Charite, Berlin